Jul 28, 2020 7:00 am EDT NeoGenomics Reports Revenue of $87 Million in the Second Quarter amid COVID-19 Pandemic
Jun 29, 2020 7:00 am EDT NeoGenomics Launches Comprehensive Suite of Solid Tumor Liquid Biopsy Tests for Cancer Patients
Jun 2, 2020 4:26 pm EDT NeoGenomics To Virtually Present At The Raymond James Human Health Innovation Conference
Jun 1, 2020 4:05 pm EDT NeoGenomics To Virtually Participate In Fireside Chat At The 40th Annual William Blair Growth Stock Conference
May 26, 2020 7:20 am EDT NeoGenomics To Virtually Participate In 17th Annual Craig-Hallum Institutional Investor Conference
May 26, 2020 5:00 am EDT NeoGenomics Enters Strategic Collaboration with Inivata to Commercialize InVisionFirst(R)-Lung Liquid Biopsy Test
May 11, 2020 4:05 pm EDT NeoGenomics To Virtually Participate In Fireside Chat At BofA Securities 2020 Health Care Conference
May 5, 2020 8:00 am EDT NeoGenomics and Bayer Collaborate to Offer NTRK Testing for Certain Colorectal and Thyroid Cancer Patients
